CommentaryJournal of Pharmacology and PharmacotherapeuticsVol. 9 | Issue 3 | 2018 | pp. 165–6Open access
An Opioid-benzodiazepine Interaction: Benzodiazepines as Opioids?
- 1,2*
- 1 Woodfield Clinical Consulting LLC, Green Valley, Arizona 85622, USA.
- 2 Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, New Jersey 08901, USA.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Neville F. Ford
Woodfield Clinical Consulting LLC, Green Valley, Arizona 85622, USA.; Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, New Jersey 08901, USA.
Email: neville@woodfieldclinical.com
Copyright: © 2018 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2018
- Received:
- Apr 30, 2018
- Accepted:
- Aug 17, 2018
How to cite
Ford, N. F. (2018). An Opioid-benzodiazepine Interaction: Benzodiazepines as Opioids? Journal of Pharmacology and Pharmacotherapeutics, 9(3), 165–6. https://doi.org/10.4103/jpp.JPP_56_18
Abstract
A review of opioid and benzodiazepine abuse has been published.[8] The authors are from the Division of Substance Abuse of the New York Psychiatric Institute. They reviewed the efforts to explain why patients using opioids supplement them with benzodiazepines. They felt that the published evidence did not support a pharmacokinetic interaction. They favored a pharmacodynamic explanation. This was based on the response of the methadone‑maintained patients, when they were queried as to why they took diazepam. The responses varied “to get high,” “have a good time,” and “produce an intense‑exciting experience.” However, none of the responses corresponded to the response of naive participants given benzodiazepines. These findings were similar to those seen in methadone‑treated patients given diazepam (20 and 40 mg)
Keywords
Subject
Article metadata
| Title | An Opioid-benzodiazepine Interaction: Benzodiazepines as Opioids? |
|---|---|
| Authors | Neville F. Ford |
| Affiliations | Woodfield Clinical Consulting LLC, Green Valley, Arizona 85622, USA.; Department of Medicine, Rutgers-RWJ Medical School, New Brunswick, New Jersey 08901, USA. |
| Corresponding author | neville@woodfieldclinical.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 9, Issue 3 (2018) |
Also in this issue
- Evolving Role of Clinical Pharmacologists in Indian Accredited Hospitalspp. 121–5
- Phosphodiesterase 7B1 as Therapeutic Target for Treatment of Cognitive Dysfunctions in Multiple Sclerosispp. 126–30
- Contribution of Italian Clinical Research for Contrast Media-Induced Nonrenal Adverse Drug Reactions over the Last Three Decades: A Systematic Reviewpp. 131–146
- Development and Implementation of Pharmacology Museum as a Teaching-Learning Tool: A Prospective, Interventional Studypp. 147–152
- Effect of Antihypertensive Pharmacotherapy on Oscillometric Pulse Wave Analysis Parameters in Treated Gujarati Hypertensives: A Cross‑Sectional Studypp. 153–159
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026